Clinical trials: Dural Arteriovenous Malformations
Arteriovenous Malformations, Aneurysm
Image Quality and Radiation Dose in Angiography
ClarityIQ is a novel X-ray imaging technology, that combines advanced real-time image noise reduction algorithms, with state-of-the-art hardware to reduce patient entrance dose significantly.
- Conditions
- Arteriovenous Malformations, Aneurysm, Stenosis, Dural Arteriovenous Malformations
- Trial name
- NCT01381952
- Testing
- Low dose DSA (75% reduction compared to normal dose) with novel X-ray imaging technology., Normal dose DSA with conventional X-ray technology
- Where
- Sweden
- Volunteers
- 20 people
- Sponsor
- Karolinska University Hospital
Arteriovenous Dural Fistula
PHIL in the Treatment of Intracranial dAVF.
This study is a prospective, multicenter, single-arm study. Patients with Dural Arteriovenous Fistulas (dAVF) have a few choice for safe treatment.
- Trial name
- PHIL dAVF (NCT03467542)
- Testing
- PHIL® Liquid Embolic System
- Where
- United States
- Volunteers
- 64 people
- Sponsor
- Microvention-Terumo, Inc.